Skip to content
Trial Eligibility
Menu

Ulcerative Colitis Clinical Trials near Boston, MA

21 studies for Ulcerative Colitis are recruiting at 28 sites within 50 miles of Boston, Massachusetts, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Ulcerative Colitis trials in the US or all trials near Boston.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Ulcerative Colitis studies enrolling near Boston

Showing 21 studies, nearest first.
  1. Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

    NCT03816345

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Dana-Farber Cancer Institute (Boston, MA); Massachusetts General Hospital Cancer Center (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  2. A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

    NCT04844606

    • Phase 3
    • Ages 2 to 19 years
    • Sex: All

    Nearest sites: Boston Children's Hospital (Boston, MA); Massachusetts General Hospital (Waltham, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  3. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

    NCT05076175

    • Phase 2/3
    • Ages 2 to 17 years
    • Sex: All

    Nearest sites: Boston Children's Hospital (Boston, MA); University of Massachusetts Chan Medical School (Worcester, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  4. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

    NCT07012395

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest sites: Site 003 (Boston, MA); Site 025 (Providence, RI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

    NCT07186101

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Brigham and Women's Hospital (Boston, MA); University Gastroenterology - Providence - West River Street (Providence, RI)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  6. High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

    NCT04331639

    • Observational
    • Ages 5 to 25 years
    • Sex: All

    Nearest site: Boston Children's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

    NCT05287126

    • Phase 2
    • Ages 12 to 17 years
    • Sex: All

    Nearest site: Boston Children's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

    NCT05987852

    • Interventional
    • Ages 18 to 85 years
    • Sex: All

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Family Members at INcreased-risk for Developing Inflammatory Bowel Disease

    NCT06655415

    • Observational
    • Ages 14 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Massachusetts General Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. Zymfentra (Infliximab-dyyb) REal World Cohort STudy

    NCT07237516

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest site: Brigham and Women's Hospital (Boston, MA)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Treatment of UC With Novel Therapeutics

    NCT06420375

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Brigham and Women's Hospital (Chestnut Hill, MA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Study of Novel Therapeutics for Acute Remedy of Colitis

    NCT06420492

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Brigham and Women's Hospital (Chestnut Hill, MA)

    Distance to nearest recruiting site
    ~6 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

    NCT06581328

    • Phase 4
    • Ages 18 to 80 years
    • Sex: All

    Nearest sites: Gastro Health Research - Framingham (Framingham, MA); University Gastroenterology (Providence, RI)

    Distance to nearest recruiting site
    ~19 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07184996

    • Phase 3
    • Ages 16 to 80 years
    • Sex: All

    Nearest sites: UMass Memorial Medical Center - Site Number: 8400121 (Worcester, MA); University Gastroenterology - GI Alliance - Site Number: 8400103 (Providence, RI)

    Distance to nearest recruiting site
    ~39 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

    NCT05230173

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest site: Gastroenterology Associates (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

    NCT06095128

    • Phase 4
    • Ages 18 to 65 years
    • Sex: All

    Nearest site: University Gastroenterology (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

    NCT06937086

    • Phase 3
    • Ages 18 to 70 years
    • Sex: All

    Nearest site: University Gastroenterology (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

    NCT07113522

    • Phase 2
    • Ages 18 to 80 years
    • Sex: All

    Nearest site: Mirador Therapeutics Selected Site (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07196748

    • Phase 3
    • Ages 12 years and older
    • Sex: All

    Nearest site: University Gastroenterology (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

    NCT07697456

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: University Gastroenterology - Providence - Staniford Street /ID# 280919 (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

    NCT07845487

    • Phase 2
    • Ages 18 to 75 years
    • Sex: All

    Nearest site: Site US-019 (Providence, RI)

    Distance to nearest recruiting site
    ~41 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining an Ulcerative Colitis clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.